Edwards Lifesciences EW Interest Expense
Discontinued — last reported Q4 '25
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Edwards Lifesciences in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The official record: Edwards Lifesciences’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edwards Lifesciences's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edwards Lifesciences's interest expense?
- Edwards Lifesciences (EW) reported interest expense of $5.1M in Q4 2025.
- How has Edwards Lifesciences's interest expense changed year-over-year?
- Edwards Lifesciences's interest expense increased by 3.0% year-over-year, from $4.95M to $5.1M.
- What is the long-term trend for Edwards Lifesciences's interest expense?
- Over 4 years (2021 to 2025), Edwards Lifesciences's interest expense has grown at a 2.6% compound annual growth rate (CAGR), from $18.4M to $20.4M.
- What does interest expense mean?
- The cost of borrowing money, paid as interest on debt.
- How do you interpret interest expense?
- An increase may signal higher debt levels or rising interest rates, potentially impacting future cash flows and profitability.
- How does interest expense compare across companies?
- Varies significantly based on capital structure; medical device firms generally carry moderate debt levels compared to capital-intensive industries.